Bangalore, Nov 17, 2008: Nestle Nutrition, the health food and nutrition arm of Switzerland's Nestle, the world’s largest food comapny has returned seven of eight nutritional bioactive molecules developed in a collaborative agreement with Indian biotechnology company Avesthagen, according to a report in an Indian business newspaper "The Mint", citing a Nestle official. 

 

The move effectively suspends a plan to use these active ingredients for a much talked about diabetes health food that the Swiss company is proposing to launch in the global market, the report said. "Nestle terminated the agreement with Avesthagen earlier this year," the report cited an email from Ms Hilary Green, head of R&D communications, Nestle SA, as saying.

 

"Nestle has returned some of the compounds to us, and we are free to further develop them on our own or with other partners," the report quoted Avesthagen Founder and Chairperson Mr Villoo Morawala Patell, as saying.